Correction to Online Text: Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9^th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

The article “Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9^th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines” published in the February 2012 supplement of CHEST (2012;141[2][Suppl]:7S-47S) contained an error in the online text. The error was on page 31S on recommendation 2.0.2.

The corrected text reads:

2.0.2. In patients with rheumatic mitral valve disease and normal sinus rhythm with a left atrial diameter >55 mm, we suggest VKA therapy (target INR, 2.5; range, 2.0-3.0) over no VKA therapy or antiplatelet (Grade 2C).

This error occurred only in the online version of the text; the PDF and print version are correct. The text has been corrected online.